News and Announcements
Enosi Announces Australia’s first Security Token Offering with bonus Utility Tokens
- Published October 16, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Enosi Australia has released a new, unique approach to blockchain technology.
- Following the collapse of the worldwide cryptocurrency market, the company has created a security token offer of ordinary shares along with bonus utility tokens.
- The Enosi Foundation, an independent third party, will control and administer the Joul token being allocated.
Enosi Australia has released a new, unique approach to blockchain technology.
The company has released a world-first in terms of blockchain project funding, a security token offer of ordinary shares along with bonus utility tokens.
The Enosi Foundation, an independent third party, will control and administer the Joul token being allocated. Investors will benefit from global adoption promoted by the Foundation.
Following the collapse of the worldwide cryptocurrency market nearly 70% of value has been lost in the global market.
Enosi has retained a true utility token in its model to drive user adoption of the platform.
Enosi Australia CEO, Steve Hoy said: “The beauty of utility tokens is that all participants of a
network are rewarded for the growth of that network. We’ve recognised the call for equity, but
believe management should not have two masters – equity holders and utility token holders.”
Enosi’s roadmap at a glance
About Enosi Australia
Enosi is disrupting the big power companies, enabling the localisation and decentralisation of power generation using the blockchain. Households will be able to choose who they buy and sell energy with – at prices they agree. The JOUL crypto-tokens will give nimble, innovative electricity retailers open-source access to the blockchain platform and shared value networks.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
